CAPSTONE THERAPEUTICS CORP Inactive Instrument
Capstone Therapeutics Corp Stock Other OTC
Equities
US14068E1091
Biotechnology & Medical Research
Financials (USD)
| Sales 2022 | 61.56M | Sales 2023 | 48.35M | Capitalization | 820K |
|---|---|---|---|---|---|
| Net income 2022 | 2M | Net income 2023 | -3M | EV / Sales 2022 | 0.56 x |
| Net Debt 2022 | 28.78M | Net Debt 2023 | 20.28M | EV / Sales 2023 | 0.44 x |
| P/E ratio 2022 |
-583
x | P/E ratio 2023 |
-0.14
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Michael Toporek
CEO | Chief Executive Officer | 59 | 17-07-13 |
Edward Schultz
DFI | Director of Finance/CFO | - | - |
Matthew Lipman
BRD | Director/Board Member | 45 | 17-07-13 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jock Holliman
BRD | Director/Board Member | 70 | 87-08-31 |
Michael Toporek
CEO | Chief Executive Officer | 59 | 17-07-13 |
Matthew Lipman
BRD | Director/Board Member | 45 | 17-07-13 |
Capstone Holding Corp. operates, through its wholly owned subsidiary, TotalStone, LLC, which is a construction materials company. TotalStone, LLC distributes masonry stone products for residential and commercial construction in the Midwest and Northeast United States. The Company, through its subsidiary, Capstone Beta, LLC, owns equity interest in Diamond Products, LLC, which is a sexual wellness products holding company. Diamond Products, LLC product portfolio includes adult toys, lingerie, games, lotions and creams that are sold globally in over 80 countries through 5,000 retailers as well as e-commerce Website.
| 1st Jan change | Capi. | |
|---|---|---|
| -0.10% | 42.63B | |
| +50.98% | 42.32B | |
| +4.43% | 40.26B | |
| -11.36% | 27.27B | |
| +5.67% | 25.24B | |
| -22.84% | 18.78B | |
| -0.20% | 12.39B | |
| +26.30% | 12.24B | |
| +6.91% | 10.95B |
